NTRA · Natera, Inc. · Earnings Call Transcripts & Audio
$413.31
-1.21 (-0.29%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$59.47B
Shares
144.14M
Volume · Sep 30
1.85M
Avg daily vol (3M)
1.38M
Natera, Inc. Earnings Call Transcripts
Quarterly earnings calls for Natera, Inc. (NTRA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲33.2%
$210.64M
−$121.48M
'22 Q3
22-11-08
▲25.6%
$217.25M
−$142.57M
'22 Q4
23-02-28
▲24.5%
$241.76M
−$136.94M
'23 Q1
23-05-09
▲31.9%
$261.40M
−$110.80M
'23 Q2
23-08-03
▲27.4%
$268.31M
−$109.03M
'23 Q3
23-11-08
▲43.2%
$311.11M
−$78.03M
'23 Q4
24-02-28
▲52.1%
$367.74M
−$67.60M
'24 Q1
24-05-09
▲58.1%
$413.35M
−$37.46M
'24 Q2
24-08-08
▲63.9%
$439.76M
−$31.59M
'24 Q3
24-11-12
▲53%
$476.06M
−$53.77M
'24 Q4
25-02-27
▲36.5%
$501.83M
−$66.94M
'25 Q1
25-05-08
▲32.2%
$546.60M
−$100.94M
'25 Q2
25-08-07
▲34.7%
$592.18M
−$87.54M
'25 Q3
25-11-06
▲39.8%
$665.50M
$47.26M
'25 Q4
26-02-26
▲38.8%
$696.64M
−$85.09M
'26 Q1
26-05-07
LATEST
▲37.7%
$752.75M
−$66.97M
'26 Q2
26-08-06
Conference
Investor event
2026-09-15
Natera, Inc. (NTRA) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-08-12
Natera, Inc. (NTRA) August 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Natera, Inc. (NTRA) Q2 2026 Earnings Call Transcript
Confident tone
Signatera Oncology Momentum
Gross Margin and COGS
International Expansion (Japan)
Revenue
$752.75M
▲ 37.7% YoY Diluted EPS
$-0.47
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Natera, Inc. (NTRA) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Natera, Inc. (NTRA) Q1 2026 Earnings Call Transcript
Confident tone
Oncology / Signatera MRD Growth
Reimbursement and Prior Authorization
Fetal Focus Product Launch (Women's Health)
Revenue
$696.64M
▲ 38.8% YoY Diluted EPS
$-0.60
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Natera, Inc. (NTRA) Q4 2025 Earnings Call Transcript
Confident tone
Revenue Growth and 2026 Guidance
MRD Volume and Adoption
Gross Margin Expansion
Revenue
$665.50M*
▲ 39.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Natera, Inc. (NTRA) Q3 2025 Earnings Call Transcript
Confident tone
Signatera MRD growth and momentum
Gross margin expansion and ASP improvement
Revenue and 2025 financial guidance raise
Revenue
$592.18M
▲ 34.7% YoY Diluted EPS
$-0.64
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Natera, Inc. (NTRA) Q2 2025 Earnings Call Transcript
Confident tone
Signatera oncology volume growth
Gross margin expansion
Medicare reimbursement expansion for noncovered indications
Revenue
$546.60M
▲ 32.2% YoY Diluted EPS
$-0.74
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Natera, Inc. (NTRA) Q1 2025 Earnings Call Transcript
Confident tone
Signatera oncology growth
Gross margin expansion
Clinical data and study readouts
Revenue
$501.83M
▲ 36.5% YoY Diluted EPS
$-0.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Natera, Inc. (NTRA) Q4 2024 Earnings Call Transcript
Confident tone
Signatera oncology growth
Gross margin and COGS progress
2025 guidance and execution risk
Revenue
$476.06M*
▲ 53% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Natera, Inc. (NTRA) Q3 2024 Earnings Call Transcript
Confident tone
Signatera oncology volumes
Reimbursement and ASP improvement
Women's health and Invitae integration
Revenue
$439.76M
▲ 63.9% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Natera, Inc. (NTRA) Q2 2024 Earnings Call Transcript
Confident tone
Signatera Oncology
Revenue Growth and Guidance Raise
ALTAIR Trial Delay
Revenue
$413.35M
▲ 58.1% YoY Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Natera, Inc. (NTRA) Q1 2024 Earnings Call Transcript
Confident tone
Signatera / Oncology Performance
Gross Margin Expansion
Women's Health Momentum
Revenue
$367.74M
▲ 52.1% YoY Diluted EPS
$-0.56
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Natera, Inc. (NTRA) Q4 2023 Earnings Call Transcript
Confident tone
Revenue and Volume Growth
Oncology / Signatera
Women's Health and Invitae Acquisition
Revenue
$311.11M*
▲ 43.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript
Revenue
$268.31M
▲ 27.4% YoY Diluted EPS
$-0.95
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Natera, Inc. (NTRA) Q2 2023 Earnings Call Transcript
Revenue
$261.40M
▲ 31.9% YoY Diluted EPS
$-0.97
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Natera, Inc. (NTRA) Q1 2023 Earnings Call Transcript
Revenue
$241.76M
▲ 24.5% YoY Diluted EPS
$-1.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Natera, Inc. (NTRA) Q4 2022 Earnings Call Transcript
Revenue
$217.25M*
▲ 25.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Natera, Inc. (NTRA) Q3 2022 Earnings Call Transcript
Revenue
$210.64M
▲ 33.2% YoY Diluted EPS
$-1.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Natera, Inc. (NTRA) Q2 2022 Earnings Call Transcript
Revenue
$198.20M
▲ 39.6% YoY Diluted EPS
$-1.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Natera, Inc. (NTRA) Q1 2022 Earnings Call Transcript
Revenue
$194.13M
▲ 27.5% YoY Diluted EPS
$-1.45
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Natera, Inc. (NTRA) Q4 2021 Earnings Call Transcript
Revenue
$173.03M*
▲ 54% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Natera, Inc. (NTRA) Q3 2021 Earnings Call Transcript
Revenue
$158.12M
▲ 61.1% YoY Diluted EPS
$-1.63
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Natera, Inc. (NTRA) Q2 2021 Earnings Call Transcript
Revenue
$142.03M
▲ 64.2% YoY Diluted EPS
$-1.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Natera, Inc. (NTRA) Q1 2021 Earnings Call Transcript
Revenue
$152.32M
▲ 62% YoY Diluted EPS
$-0.74
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Natera, Inc. (NTRA) Q4 2020 Earnings Call Transcript
Revenue
$112.38M*
▲ 35% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Natera, Inc. (NTRA) Q3 2020 Earnings Call Transcript
Revenue
$98.14M
▲ 26% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Natera, Inc. (NTRA) Q2 2020 Earnings Call Transcript
Revenue
$86.47M
▲ 16.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Natera, Inc. (NTRA) Q1 2020 Earnings Call Transcript
Revenue
$94.01M
▲ 40.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-26
Natera, Inc. (NTRA) Q4 2019 Earnings Call
Revenue
$83.24M
▲ 24.3% YoY Diluted EPS
$-0.46
Gross margin
46.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–30 of 30 earnings calls
Key facts
CIK
1604821
CUSIP
632307104
13F (30d)
22 filings
16 filers
Visit website
Investor relations